Panos Georgios D, Kozeis Nikolaos, Balidis Miltiadis, Moschos Marilita M, Hafezi Farhad
Department of Ophthalmology, Ipswich Hospital NHS Trust, University of Cambridge, Ipswich, Suffolk, UK.
Ophthalmica Institute, Thessaloniki, Central Macedonia, Greece.
Open Ophthalmol J. 2017 Jul 31;11:211-216. doi: 10.2174/1874364101711010211. eCollection 2017.
Since the late 1990s corneal crosslinking (CXL) has been proposed as a new treatment option which can stop progression of keratoconus with promising results in adults.
Keratoconus presents a higher rate and faster progression in paediatric patients and for this reason prompt and effective treatment is essential. Due to its success in adult keratoconus patients, CXL has been recently applied to children in order to stop or slow progression of keratoconus in paediatric patients.
This article will present an update of the literature on the topic of CXL in this age group.
自20世纪90年代末以来，角膜交联术（CXL）被提出作为一种新的治疗选择，可阻止圆锥角膜进展，在成人中取得了有前景的结果。
圆锥角膜在儿科患者中发病率更高且进展更快，因此及时有效的治疗至关重要。由于其在成人圆锥角膜患者中的成功，角膜交联术最近已应用于儿童，以阻止或减缓儿科患者圆锥角膜的进展。
本文将介绍该年龄组角膜交联术相关主题的文献更新情况。
